
NYSEHealthcareMedical - Devices
أحدث البيانات المتاحة
27.24 US$
+0.28 US$ · +1.04%
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
الإغلاق السابق
27.24 US$
+0.28 US$ · +1.04%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
نطاق اليوم
السعر الحالي 27.24 US$
نطاق 52 أسبوعًا
السعر الحالي 27.24 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
88
قيمة جذابة جدًا
المشاعر
58
مختلط
المخاطر
32
مخاطر متوسطة
الزخم
45
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
نطاق اليوم
السعر الحالي 27.24 US$
نطاق 52 أسبوعًا
السعر الحالي 27.24 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 6.16 مليار USD | 5.81 مليار USD | 5.55 مليار USD | 5.22 مليار USD | 5.21 مليار USD |
| تكلفة البضاعة المباعة | 1.96 مليار USD | 1.73 مليار USD | 1.65 مليار USD | 1.52 مليار USD | 1.51 مليار USD |
| الربح الإجمالي | 4.21 مليار USD | 4.08 مليار USD | 3.9 مليار USD | 3.7 مليار USD | 3.7 مليار USD |
| البحث والتطوير | 346 مليون USD | 343 مليون USD | 339 مليون USD | 345 مليون USD | 356 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 3.04 مليار USD | 2.9 مليار USD | 2.83 مليار USD | 2.71 مليار USD | 2.64 مليار USD |
| نفقات التشغيل | 3.41 مليار USD | 3.42 مليار USD | 3.47 مليار USD | 3.25 مليار USD | 3.11 مليار USD |
| دخل الفوائد | 28.07 مليون USD | 24.01 مليون USD | 34.13 مليون USD | 13.99 مليون USD | 6 مليون USD |
| مصاريف الفوائد | 141.33 مليون USD | 150.06 مليون USD | 132.51 مليون USD | 79.95 مليون USD | 79.99 مليون USD |
| الاستهلاك والإطفاء | 573 مليون USD | 555 مليون USD | 527 مليون USD | 548 مليون USD | 563 مليون USD |
| الدخل التشغيلي | 794 مليون USD | 657 مليون USD | 425 مليون USD | 450 مليون USD | 593 مليون USD |
| صافي الدخل | 625 مليون USD | 412 مليون USD | 263 مليون USD | 223 مليون USD | 524 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
| الإجراء | تاريخ النفاذ | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
تقسيم الأسهم | 15 أكتوبر 2014 | 5:2 | — | — |
تقسيم الأسهم | 16 ديسمبر 2003 | 2:1 | — | — |
تقسيم الأسهم | 7 أغسطس 2000 | 9:11 | — | — |
ساري 15 أكتوبر 2014
5:2
ساري 16 ديسمبر 2003
2:1
ساري 7 أغسطس 2000
9:11
صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Total International Stock ETFVXUS10.71 مليون0.00%665.7 مليار USD0.05%84.82 US$+0.86%
Vanguard FTSE Emerging Markets ETFVWO10.45 مليون0.01%168.5 مليار USD0.06%59.76 US$+1.12%
Dimensional - International Core Equity 2 ETFDFIC8.02 مليون0.05%15.02 مليار USD0.22%37.53 US$+0.64%
Avantis International Equity ETFAVDE7.34 مليون0.04%19.22 مليار USD0.23%89.80 US$+0.58%
Dimensional World ex U.S. Core Equity 2 ETFDFAX4.88 مليون0.04%12.34 مليار USD0.28%37.08 US$+0.76%
State Street SPDR S&P Kensho New Economies Composite ETFKOMP2.14 مليون0.08%2.61 مليار USD0.20%66.35 US$+1.13%
Vanguard FTSE All-World ex-US ETFVEU1.72 مليون0.00%98.6 مليار USD0.04%82.82 US$+0.78%
Vanguard International High Dividend Yield ETFVYMI858.89 ألف0.00%22.8 مليار USD0.07%100.66 US$+0.60%
Vanguard Total International Stock ETFVXUS
Vanguard FTSE Emerging Markets ETFVWO
Dimensional - International Core Equity 2 ETFDFIC
Avantis International Equity ETFAVDE
Dimensional World ex U.S. Core Equity 2 ETFDFAX
State Street SPDR S&P Kensho New Economies Composite ETFKOMP
Vanguard FTSE All-World ex-US ETFVEU
Vanguard International High Dividend Yield ETFVYMIالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.